June 26 (Reuters) - Bionomics Ltd (BNO) :
- RESULTS OF AGITATION TRIAL INDICATED THAT BNC210 TREATMENT DID NOT DIFFERENTIATE FROM PLACEBO ON PRIMARY & SECONDARY EFFICACY END POINTS
- TRIAL RESULTS DO NOT SUPPORT FURTHER DEVELOPMENT OF BNC210 FOR TREATMENT OF AGITATION, TO INVEST IN PURSUING DOSE STUDY FOR PTSD
June 26 (Reuters) - Bionomics Ltd (BNO) : RESULTS OF AGITATION...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)